Common Contracts

Contract

Clinicaltrial Agreement • August 21st, 2018

• Contract Type
  Clinicaltrial Agreement
• Filed
  August 21st, 2018

AMENDMENT 2 TO CLINICAL TRIAL AGREEMENT DODATEK Č. 2 KE SMLOUVĚ O KLINICKÉM HODNOCENÍ THIS AMENDMENT 2 TO CLINICALTRIAL AGREEMENT (“Amendment 2”), is effective on the day of the publishing in accordance with the Act no. 340/2015 Coll. On the Register of Contracts (“Amendment 2 Effective Date”), is by and among:Fakultní nemocnice Královské Vinohrady, Šrobárova 1150/50, 100 34 Praha 10, Czech Republic, ID: 00064173, Tax ID: CZ 00064173,Ref. No. KH 54/2016, cost center: 52105, represented by Assoc. Prof. MUDr. Robert Grill, Ph.D., MHA, Director (“Institution”) and Acerta Pharma LLC, a Delaware limited liability company, located at 121 Oyster Point Boulevard, South San Francisco, CA 94080, USA (“Acerta” or “Sponsor”) The Institution and Sponsor are hereinafter individually referred to as a (“Party”) and are collectively known as the (“Parties”). TENTO DODATEK Č. 2 KE SMLOUVĚO KLINICKÉM HODNOCENÍ (dále „Dodatek č . 2“) nabývá účinnosti ke dni zveřejnění dle zákona č. 340/2015 Sb., o regis